Contraceptive Provision to Adolescent Females Prescribed Teratogenic Medications
- PMID: 26676050
- DOI: 10.1542/peds.2015-1454
Contraceptive Provision to Adolescent Females Prescribed Teratogenic Medications
Abstract
Background and objectives: Rates of adult women receiving contraceptive provision when simultaneously prescribed a known teratogen are alarmingly low. The prevalence of this behavior among pediatric providers and their adolescent patients is unknown. The objective of this study was to describe pediatric provider behaviors for prescribing teratogens concurrently with counseling, referral, and/or prescribing of contraception (collectively called contraceptive provision) in the adolescent population.
Methods: A retrospective review was conducted examining visits in 2008-2012 by adolescents aged 14 to 25 years in which a known teratogen (US Food and Drug Administration pregnancy risk category D or X) was prescribed. The electronic medical records were queried for demographic information, evidence of contraceptive provision, and menstrual and sexual histories. The data were analyzed using standard statistical methods.
Results: Within 4172 clinic visits, 1694 females received 4506 prescriptions for teratogenic medications. The most commonly prescribed teratogens were topiramate, methotrexate, diazepam, isotretinoin, and enalapril. The subspecialties prescribing teratogens most frequently were neurology, hematology-oncology, and dermatology. Overall, contraceptive provision was documented in 28.6% of the visits. Whites versus nonwhites and older versus younger girls were more likely to receive contraceptive provision. The presence of a federal risk mitigation system for the teratogen also increased the likelihood of contraceptive provision.
Conclusions: Our data demonstrate female adolescents prescribed teratogens receive inadequate contraception provision, which could increase their risk for negative pregnancy outcomes. Although the presence of a federal risk mitigation system appears to improve contraceptive provision, these systems are costly and, in some instances, difficult to implement. Efforts to improve provider practices are needed.
Copyright © 2016 by the American Academy of Pediatrics.
Comment in
-
All Adolescents Deserve Routine Conversations About Sexual Activity and Pregnancy Prevention.Pediatrics. 2016 Jan;137(1). doi: 10.1542/peds.2015-3826. Epub 2015 Dec 16. Pediatrics. 2016. PMID: 26676051 No abstract available.
-
Young Women Prescribed Teratogenic Medications Are Often Not Provided with Contraceptives.Perspect Sex Reprod Health. 2016 Jun;48(2):104. doi: 10.1363/48e9616. Perspect Sex Reprod Health. 2016. PMID: 27303869 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
